Trevi Therapeutics Stock Forecast - Accumulation Distribution
| TRVI Stock | USD 2.91 0.18 6.59% |
Trevi Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Trevi Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Trevi |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 4941.1 | 161941.0 |
| Check Trevi Therapeutics Volatility | Backtest Trevi Therapeutics | Information Ratio |
Trevi Therapeutics Trading Date Momentum
| On November 22 2024 Trevi Therapeutics was traded for 2.91 at the closing time. The top price for the day was 2.93 and the lowest listed price was 2.66 . The trading volume for the day was 1.8 M. The trading history from November 22, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 6.19% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Trevi Therapeutics to competition |
Other Forecasting Options for Trevi Therapeutics
For every potential investor in Trevi, whether a beginner or expert, Trevi Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Trevi Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Trevi. Basic forecasting techniques help filter out the noise by identifying Trevi Therapeutics' price trends.Trevi Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Trevi Therapeutics stock to make a market-neutral strategy. Peer analysis of Trevi Therapeutics could also be used in its relative valuation, which is a method of valuing Trevi Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Trevi Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Trevi Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Trevi Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Trevi Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Trevi Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Trevi Therapeutics shares will generate the highest return on investment. By undertsting and applying Trevi Therapeutics stock market strength indicators, traders can identify Trevi Therapeutics entry and exit signals to maximize returns.
Trevi Therapeutics Risk Indicators
The analysis of Trevi Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Trevi Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting trevi stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.1 | |||
| Semi Deviation | 3.62 | |||
| Standard Deviation | 3.97 | |||
| Variance | 15.74 | |||
| Downside Variance | 15.87 | |||
| Semi Variance | 13.12 | |||
| Expected Short fall | (3.45) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether Trevi Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Trevi Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Trevi Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Trevi Therapeutics Stock:Check out Historical Fundamental Analysis of Trevi Therapeutics to cross-verify your projections. For more detail on how to invest in Trevi Stock please use our How to Invest in Trevi Therapeutics guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trevi Therapeutics. If investors know Trevi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trevi Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.44) | Return On Assets (0.37) | Return On Equity (0.60) |
The market value of Trevi Therapeutics is measured differently than its book value, which is the value of Trevi that is recorded on the company's balance sheet. Investors also form their own opinion of Trevi Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Trevi Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trevi Therapeutics' market value can be influenced by many factors that don't directly affect Trevi Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trevi Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Trevi Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trevi Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.